Oncology Hematologic / Blood Related Cancers Leukemia MDS and CMML 1 Treatment Naive
Categories
Protocols
BEIGENE-BGB-11417-103 Phase I/II OPEN TO ACCRUAL
A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients with Myeloid Malignancies